Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy) and dual GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound) are injectable medications used for type 2 diabetes management and weight loss
Myers Cocktail Glutathione IV B12 (complimentary) Walk in feeling restored and camera-ready: deep hydration with a bright, antioxidant finish
Until recently, GLP-1s were only indicated and marketed for the management of type II diabetes
But beneath the glossy marketing lies a growing unease
Both can effectively treat or prevent B12 deficiency, but they differ in chemical structure, stability, cost, and clinical applications
Glutathione is concentrated inside these structures precisely because it neutralizes those byproducts